% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. Message Board

  • chinaman.nyc2003 chinaman.nyc2003 Dec 29, 2013 11:51 AM Flag

    my view: breakdown of MACK's worth right now of $13 per share

    MM121: 8 dollars. (based on bio-marker driven positive phase 2 in both breast and ovarian, and having Sanofi as big pharm partner who foots the bills on clinical trial phase 3 to come)

    MM398: 3 dollars. (to increase to 5-10 when phase 3 succeeds. 5 if trial comes out positive as expected. 10 if data as strong as first line gem. recent nejm published study showed gem os at 7 plus month only and with addn of albumin paxel,,only 8.5 months but loads of myelosuppresion and significant neuropathy)

    rest of the pipeline: 2 dollars (conservative but hey)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.5199-0.0101(-0.18%)10:04 AMEDT